■胰岛素样生长因子-1(IGF-1)在体内各种组织和细胞的生长和代谢功能中起着至关重要的作用。最近,IGF-1与骨关节炎(OA)之间的相关性受到越来越多的关注.然而,目前关于IGF-1水平与OA之间的相关性研究存在争议。此外,身体质量指数(BMI)的具体方式,OA的一个关键风险因素,介导IGF-1水平对OA的影响尚不清楚。
■本研究旨在探讨四个身体部位IGF-1水平与OA之间的双向因果联系,并探讨BMI如何影响IGF-1对这些类型OA的影响。
■双样本孟德尔随机化(MR)及其组合形式用于研究IGF-1水平与四种类型OA之间的双向关系,以及BMI在IGF-1水平对OA影响中的中介作用。来自各种全基因组关联研究(GWAS)和多种分析方法的数据,包括逆方差加权,MR-Egger回归,使用加权中位数。敏感性分析,比如MR-Egger截获,CochranQ测试,leave-one-out,和MR-PRESSO,进行以确保结果的稳健性。
■较高的IGF-1水平与膝关节风险增加相关(或,1.07;95%CI,1.01-1.03;p=1.49e-01;q=9.86e-03),臀部(或,1.13;95%CI,1.06-1.20;p=7.61e-05;q=7.44e-05),和手OA(或,1.09;95%CI,1.01-1.17;p=1.88e-02;q=1.15e-02),但不是脊柱OA但不是脊柱OA(或,1.05;95%CI,0.99-1.10;p=9.20e-02;q=5.52e-02)。不同类型的OA不影响IGF-1水平。BMI介导与较高IGF-1相关的OA风险增加,包括通过BMI间接脊柱OA风险。
■该研究阐明了IGF-1水平与身体各个部位的OA之间的双向因果关系,强调BMI在IGF-1水平对OA影响中的中介作用。这为预防OA提供了有价值的见解,诊断,和治疗策略。未来的研究将扩大我们的研究范围,以包括更广泛的种族,并探索所涉及的潜在机制。
UNASSIGNED: Insulin-like Growth Factor-1 (IGF-1) plays a crucial role in the growth and metabolic functions of various tissues and cells in the body. Recently, there has been increased attention to the association between IGF-1 and osteoarthritis (OA). However, there is controversy in current research regarding the correlation between IGF-1 levels and OA. Furthermore, the specific manner in which Body Mass Index (BMI), a key risk factor for OA, mediates the impact of IGF-1 levels on OA remains unclear.
UNASSIGNED: This study aimed to investigate the bidirectional causal link between IGF-1 levels and OA in four body regions, and to explore how BMI influences the impact of IGF-1 on these types of OA.
UNASSIGNED: Two-sample Mendelian Randomization (MR) and its combined forms were utilized to investigate the bidirectional relationship between IGF-1 levels and four types of OA, as well as the mediating role of BMI in the impact of IGF-1 levels on OA. Data from various Genome-Wide Association Studies (GWAS) and multiple analytical methods, including inverse variance weighted, MR-Egger regression, and weighted median were utilized. Sensitivity analyses, such as MR-Egger intercept, Cochran Q test, leave-one-out, and MR-PRESSO, were conducted to ensure the robustness of the results.
UNASSIGNED: Higher IGF-1 levels are correlated with an increased risk for knee (OR, 1.07; 95% CI, 1.01-1.03; p = 1.49e-01; q = 9.86e-03), hip (OR, 1.13; 95% CI, 1.06-1.20; p = 7.61e-05; q = 7.44e-05), and hand OA (OR, 1.09; 95% CI, 1.01-1.17; p = 1.88e-02; q = 1.15e-02), but not spine OA but not spine OA (OR, 1.05; 95% CI, 0.99-1.10; p = 9.20e-02; q = 5.52e-02). Different types of OA do not affect IGF-1 levels. BMI mediates the increase in OA risk associated with higher IGF-1, including indirect spine OA risk through BMI.
UNASSIGNED: The study elucidates the bidirectional causality between IGF-1 levels and OA in various body parts, highlighting BMI\'s mediating role in the impact of IGF-1 levels on OA. This provides valuable insights for OA prevention, diagnosis, and treatment strategies. Future research will expand our study to include a broader spectrum of ethnicities and explore the underlying mechanisms involved.